Performance Evaluation of the AllCheck hCG Card Point-of-Care Device and Method Comparison with the Alere hCG Cassette Assay for Pregnancy Test
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Immunochromatographic point-of-care (POC) devices ae widely used by laboratories and lay users for urinary human chorionicgonadotropin (hCG) detection. Performance evaluation of pregnancy POC devices is rarely published. We performed an analytical and clinical vali dation of the newly introduced AllCheck hCG Card assay and compared it with the Alere hCG Cassette comparative assay. Methods: The analytical performance of the assay was evaluated using an international standard material for hCG, as per the protocol recom mended in the Clinical and Laboratory Standards Institute (CLSI) guideline. Clinical validation and comparison study with the comparative method were performed with remnant urine samples from pregnant and non-pregnant women. Results: Probit analysis showed an analytical sensitivity of 15.82 mIU/mL. The precision of the assay was validated at a threshold of 30%. Cross-reactivity with luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone was not observed. Comparison with the comparative assay showed a negative percent agreement of 100.0% (95% confidence interval [CI]: 92.9%-100.0%) and a positive percent agreement of 96.4% (95% CI: 89.9%-98.8%). Cohen’s kappa value was 0.952 (95% CI: 0.899-1.000). Conclusions: Overall, we validated the performance of the urine hCG POC device and suggest that probit regression is suitable for qualitative tests other than molecular tests. The AllCheck hCG Card device satisfied the demanding standards suggested by the CLSI guideline and was suitable for clinical use.
Abstract
Background: Immunochromatographic point-of-care (POC) devices ae widely used by laboratories and lay users for urinary human chorionicgonadotropin (hCG) detection. Performance evaluation of pregnancy POC devices is rarely published. We performed an analytical and clinical vali dation of the newly introduced AllCheck hCG Card assay and compared it with the Alere hCG Cassette comparative assay. Methods: The analytical performance of the assay was evaluated using an international standard material for hCG, as per the protocol recom mended in the Clinical and Laboratory Standards Institute (CLSI) guideline. Clinical validation and comparison study with the comparative method were performed with remnant urine samples from pregnant and non-pregnant women. Results: Probit analysis showed an analytical sensitivity of 15.82 mIU/mL. The precision of the assay was validated at a threshold of 30%. Cross-reactivity with luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone was not observed. Comparison with the comparative assay showed a negative percent agreement of 100.0% (95% confidence interval [CI]: 92.9%-100.0%) and a positive percent agreement of 96.4% (95% CI: 89.9%-98.8%). Cohen’s kappa value was 0.952 (95% CI: 0.899-1.000). Conclusions: Overall, we validated the performance of the urine hCG POC device and suggest that probit regression is suitable for qualitative tests other than molecular tests. The AllCheck hCG Card device satisfied the demanding standards suggested by the CLSI guideline and was suitable for clinical use.
참고문헌 (12)
- Stenman UH, "The classification, functions and clinical use of different isoforms of HCG", Hum Reprod Update, 12, pp.769~784 (2006)
- Birken S, "Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine", Endocrinology, 123, pp.572~583 (1988)
- Kovalevskaya G, "Hyperglycosylated HCG expression in pregnancy : cellular origin and clinical applications", Mol Cell Endocrinol, 260-262, pp.237~243 (2007)
- Norman RJ, "Relationship between blood and urine concentrations of intact human chorionic gonadotropin and its free subunits in early pregnancy", Obstet Gynecol, 69, pp.590~593 (1987)
- Kato Y, "Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy", J Clin Endocrinol Metab, 66, pp.1197~1201 (1988)
- Herskovits AZ, "False-negative urine human chorionic gonadotropin testing in the clinical laboratory", Lab Med, 51, pp.86~93 (2020)
- Cervinski MA, "Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy", Clin Chim Acta, 406, pp.81~85 (2009)
- Griffey RT, ""Hook-like effect"causes false-negative point-of-care urine pregnancy testing in emergency patients", J Emerg Med, 44, pp.155~160 (2013)
- Sturgeon C, "Recommendations for validation testing of home pregnancy tests(HPTs)in Europe", Clin Chem Lab Med, 59, pp.823~835 (2021)
- User protocol for evaluation of qualitative test performance; approved guideline—second edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document EP12-A2 (2008)
- Kamer SM, "Analytical sensitivity of four commonly used hCG point of care devices", Clin Biochem, 48, pp.448~452 (2015)
- Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline—second edition, "Clinical and Laboratory Standards Institute", Clinical and Laboratory Standards Institute, ~, pp.CLSI document EP17-A2 (2012)